Basic Information
KORSUVA SOLUTION FOR INJECTION 50 MICROGRAMS/ ML
INJECTION, SOLUTION
Regulatory Information
SIN16582P
August 25, 2022
Prescription Only
Therapeutic
INTRAVENOUS BOLUS
August 10, 2023
June 3, 2025
Company Information
Active Ingredients
Difelikefalin acetate eqv Difelikefalin
Strength: 0.05mg/ ml
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
Indication Information
**4.1 Therapeutic indications** KORSUVA is indicated for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis (see section 5.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).